← All Fennec Pharmaceuticals INC filings

Fennec Pharmaceuticals INC Form 4 insider transactions

NASDAQ

25 Mar 2024

FENC

Form 4: Fennec Pharmaceuticals CFO Robert Andrade Sells Shares Under 10b5-1 Plan

Robert Andrade, CFO of Fennec Pharmaceuticals, sold 13,975 common shares at $10.9975 per share on March 25, 2024, under a pre-arranged 10b5-1 trading plan.